Journal of Surgery Concepts & Practice >

2022 , Vol. 27 >Issue 02: 128 - 130

DOI: https://doi.org/10.16139/j.1007-9610.2022.02.008

Experts forum

Surgical treatment strategy for complex bilateral multiple liver metastases of colorectal carcinoma

Expand

Received date: 2022-03-08

  Online published: 2022-06-16

Fold

Cite this article

BAO Quan, XING Baocai . Surgical treatment strategy for complex bilateral multiple liver metastases of colorectal carcinoma[J]. Journal of Surgery Concepts & Practice, 2022 , 27(02) : 128 -130 . DOI: 10.16139/j.1007-9610.2022.02.008

References

[1] Creasy JM, Sadot E, Koerkamp BG, et al. Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?[J]. Surgery, 2018, 163(6):1238-1244.
[2] Andreou A, Knitter S, Schmelzle M, et al. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival[J]. Surgery, 2021, 169(5):1061-1068.
[3] Elias D, Baton O, Sideris L, et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases[J]. J Surg Oncol, 2005, 90(1):36-42.
[4] Evrard S, Rivoire M, Arnaud J, et al. Unresectable co-lorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection[J]. Br J Surg, 2012, 99(4):558-565.
[5] Imai K, Allard MA, Castro Benitez C, et al. Long-term outcomes of radiofrequency ablation combined with he-patectomy compared with hepatectomy alone for colorectal liver metastases[J]. Br J Surg, 2017, 104(5):570-579.
[6] Tanis E, Nordlinger B, Mauer M, et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983[J]. Eur J Cancer, 2014, 50(5):912-919.
[7] Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the Interventional Oncology Sans Frontieres meeting 2013[J]. Eur Radiol, 2015, 25(12):3438-3454.
[8] Lee H, Heo JS, Cho YB, et al. Hepatectomy vs. radiofrequency ablation for colorectal liver metastasis: a propensity score analysis[J]. World J Gastroenterol, 2015, 21(11):3300-3307.
[9] van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer[J]. Ann Oncol, 2016, 27(8):1386-1422.
[10] Petrelli F, Comito T, Barni S, et al. Stereotactic body radio-therapy for colorectal cancer liver metastases: a systematic review[J]. Radiother Oncol, 2018, 129(3):427-434.
[11] Franzese C, Comito T, Toska E, et al. Predictive factors for survival of oligometastatic colorectal cancer treated with stereotactic body radiation therapy[J]. Radiother Oncol, 2019, 133:220-226.
[12] Jackson WC, Tao Y, Mendiratta Lala M, et al. Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases[J]. Int J Radiat Oncol Biol Phys, 2018, 100(4):950-958.
Options
Outlines

/

〈 〉